AKRO   $32.71  4.84% Market Closed After Close 32.2 -1.56%

Akero Therapeutics Inc
Total Cash 760.19M
totalCashPerShare 10.949
EBITDA -234.17M
Total Debt 35.91M
quickRatio 24.386
currentRatio 24.893
Total Revenue
debtToEquity 4.5
Revenue/Share
ROA -0.19147
ROE -0.28869
grossProfits
freeCashflow -124.96M
operatingCashflow -190.94M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.55B
forwardPE -8.71111
floatShares 55.03M
sharesOutstanding 69.43M
sharesShort 4.72M
sharesShortPriorMonth 7.16M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.05%
heldPercentInstitutions 1.06%
Short Ratio help_outline 8.67%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 11.532
Price To Book help_outline 3.06
earningsQuarterlyGrowth
netIncomeToCommon -204.18M
trailingEps -3.44%
forwardEps -4.05%
enterpriseToEbitda -6.61
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.9 3Q 2024
institutionsCount 229
lastUpdated Nov. 7, 2024, 3:01 a.m.